Arrowhead Research Corporation's Nanotope, a Pasadena, Calif.-based medical research organization, entered into an agreement with Smith & Nephew to develop cartilage regeneration products, according to an Arrowhead news release.
Spinal Tech
The Food and Drug Administration issued 28 orthopedic- and spine-related 510(k) clearances in August, according to an FDA report.
The American Academy of Orthopaedic Surgeons supports the FDA 510k program and refutes the claim that the pre-market approval process is safer and better able to identify products than the current FDA 510k clearance process, according to an AAOS Now…
The FDA said it plans to revoke approval of Menaflex, ReGen Biologics' knee implant, after a 2009 review found four New Jersey congressmen and the FDA commissioner had improperly interceded in the approval process, according to a report by the…
Stanmore Implants Worldwide, a London-based orthopedic implant manufacturer, has acquired Acrobot, a U.K.-based robotic medical device company, according to a Dow Jones report.
Advertisement
Biomet reported a net sales increase of 2 percent worldwide to $641 million during the first quarter of the 2011 fiscal year, which is less than the company expected, according to a company news release.
NuVasive, a medical device company developing treatment for minimally invasive spine surgery, has initiated a patent infringement lawsuit against Globus Medical regarding lateral fusion technology, according to a NuVasive news release.
Medical Tracking Solutions, a Jacksonville, Fla.-based medical implant technology firm, recently launched iTraycer, an iPhone application that tracks medical implants according to a Kansas City Star report.
Alphatec Holdings, a Carlsbad, Calif.-based medical device company focused on treating spinal disorders, has named former Johnson & Johnson CFO Michael O'Neill as the company's new CFO, vice president and treasurer, according to a company news release.
Wright Medical Group received a $2.4 million grant from the U.S. Department of Defense to fund a clinical study of OSTEOSET T bone graft substitute pellets in combat-related open fracture wounds, according to a company news release.